Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of furazolidone powder cas 67-45-8 in China. Welcome to wholesale bulk high quality furazolidone powder cas 67-45-8 for sale here from our factory. Good service and reasonable price are available.
Furazolidone powder is a nitrofuran-based antimicrobial agent characterized by its bright yellow crystalline appearance and slight solubility in water, often used in veterinary and aquaculture settings to combat bacterial and protozoal infections. This fine, odorless powder exhibits broad-spectrum activity against Gram-positive and Gram-negative bacteria, including Salmonella, Escherichia coli, and Vibrio species, as well as certain parasites like Giardia and Trichomonas. Its mechanism of action involves inhibiting multiple bacterial enzyme systems, particularly interfering with nucleic acid synthesis and cellular metabolism, leading to microbial cell death. The powder is stable under normal storage conditions but degrades upon prolonged exposure to light or moisture, requiring protection in airtight, opaque containers. When administered, it demonstrates rapid absorption and distribution, though its use is carefully regulated due to potential residues and environmental concerns. In aquatic environments, it effectively controls infections in fish and shellfish, while in livestock, it treats enteric infections, often being incorporated into feed or water systems. The compound's efficacy, combined with its affordability, has made it a historically significant tool in animal health management, though alternatives are increasingly sought due to emerging resistance and regulatory restrictions on nitrofurans. Proper handling and dosage are critical to minimize unintended ecological impacts while maintaining therapeutic effectiveness.
|
|
|
|
Chemical Formula |
C8H7N3O5 |
|
Exact Mass |
225 |
|
Molecular Weight |
225 |
|
m/z |
225 (100.0%), 226 (8.7%), 226 (1.1%), 227 (1.0%) |
|
Elemental Analysis |
C, 42.68; H, 3.13; N, 18.66; O, 35.53 |
Furazolidone powder is a drug used to treat various neurological disorders, and its mechanism of action mainly involves the regulation of calcium ion channels. The following is a detailed explanation of the mechanism of action of furazolidone:
It mainly exerts its pharmacological effects by inhibiting calcium ion channels on the cell membrane. Calcium ion channels play a crucial regulatory role in neurons and cardiomyocytes, regulating changes in intracellular calcium ion concentration, thereby affecting multiple physiological processes such as cell excitability, neurotransmitter release, and cellular metabolism.
1.1 Types of Calcium Ion Channels
There are various types of calcium ion channels on the cell membrane, mainly including:
L-type Calcium Channels:
Widely distributed in the heart and smooth muscle cells, they regulate muscle contraction and smooth muscle tension.
N-type Calcium Channels:
located on the presynaptic membrane of neuronal terminals, regulate the release of neurotransmitters.
T-type Calcium Channels:
Found in neurons and cardiomyocytes, they are involved in regulating cellular excitability.
1.2 Target of action
It mainly exerts its pharmacological effects by affecting L-type and N-type calcium ion channels.
L-type calcium channel inhibition:
Furazolidone can selectively block L-type calcium channels in myocardial cells, thereby reducing calcium ion influx, lowering the excitability and contractility of myocardial cells, and helping to treat cardiovascular diseases such as coronary heart disease and arrhythmia.
Inhibition of N-type calcium ion channels:
Furazolidone plays a role in the treatment of migraine and other neurological diseases by inhibiting the N-type calcium ion channels at the end of neurons, reducing the release of neurotransmitters such as dopamine and norepinephrine, and thereby regulating neurotransmission.
In addition to the direct effect of calcium ion channels, furazolidone also has antihistamine properties. Histamine is a neurotransmitter involved in various physiological and pathological processes, including vascular regulation, neurotransmission, and inflammatory response. Furazolidone can inhibit the histamine H1 receptor, thereby reducing the effect of histamine, which plays an important role in the treatment of allergic diseases and the alleviation of edema caused by increased vascular permeability.
Recent studies have shown that furazolidone may also have antioxidant properties. Oxidative stress is one of the common pathophysiological mechanisms in many neurological diseases, involving damage to cell membranes, proteins, and DNA by free radicals and oxidants. Furazolidone may help protect neurological health by inhibiting oxidative stress response and reducing cellular oxidative damage.
4.1 Clinical Application
Furazolidone is mainly used for the treatment of the following diseases:
Migraine:
By inhibiting neurotransmitter release and reducing vasomotor response, the frequency and intensity of migraine attacks are reduced.
Fainting:
Preventing fainting caused by hemodynamic disorders by regulating the contraction force of cardiac muscles and the cardiac conduction system.
Coronary heart disease and arrhythmia:
By inhibiting L-type calcium ion channels in the heart, the increase in calcium ion concentration in myocardial cells is reduced, improving cardiac function.
4.2 Adverse reactions
Although furazolidone is an effective drug, it may also cause some adverse reactions, including:
Sleepiness:
Due to its inhibitory effect on the central nervous system, furazolidone may cause drowsiness and lack of concentration.
Weight gain:
Long term use may lead to weight gain, especially among adolescents and young adults.
Movement disorders:
A small number of patients may experience movement disorders such as lack of coordination or tremors.
Other:
May also include indigestion, skin allergies, etc.
The main mechanism of action of furazolidone is to inhibit bacterial growth and reproduction by interfering with DNA synthesis and cell wall formation. Specifically, it can inhibit the activity of bacterial DNA gyrase, prevent bacterial DNA synthesis, and thus exert bactericidal effects. In addition, furazolidone can further inhibit bacterial growth by interfering with bacterial oxidoreductases.
Gastrointestinal infection:
Furazolidone has good therapeutic effects on gastrointestinal infections such as enteritis and dysentery caused by Escherichia coli and Shigella. It can effectively control infections by inhibiting the DNA synthesis and cell wall formation of these bacteria.
Furazolidone also has a certain therapeutic effect on gastrointestinal diseases such as gastric ulcers, which may be related to its inhibition of bacterial growth and reduction of inflammatory response.
Helicobacter pylori infection:
Furazolidone is often used in combination with other drugs to eradicate Helicobacter pylori. Helicobacter pylori is an important pathogen causing gastric diseases such as gastritis and gastric ulcers, and the broad-spectrum antibacterial effect of furazolidone makes it one of the important drugs for treating Helicobacter pylori infection.
Urinary tract infection:
Furazolidone can also be used to treat urinary tract infections such as cystitis and urethritis. These infections are usually caused by pathogens such as Neisseria gonorrhoeae and Chlamydia, and furazolidone has strong antibacterial activity against these pathogens.
Other infectious diseases:
In addition to the main uses mentioned above, furazolidone can also be used to treat diseases such as trichomonas vaginitis, amoebic dysentery, and Giardia. These diseases are usually caused by different pathogens, but the broad-spectrum antibacterial effect of furazolidone also makes it effective against these pathogens.
The synthesis of Furazolidone powder generally starts from ethanolamine or related compounds and proceeds through multiple reactions to obtain the target product. One common synthetic route is obtained by reacting 3-amino-2-oxazolidinone (or similar intermediate) with 5-nitrofurfural or its derivatives. Here is a simplified synthesis route example:
Detailed steps and chemical equations
Steps:
Ethanolamine reacts with urea under appropriate conditions to produce β - hydroxyethyl urea.
Further reaction of β - hydroxyethyl urea, followed by nitrosylation, diazotization and other steps, yields 3-amino-2-oxazolidinone.
C2H7NO+H4N2O → β - hydroxyethyl urea → (a series of reactions) → C3H6N2O2
Steps:
(1) Reacting 3-amino-2-oxazolidinone with 5-nitrofurfural or its esters (such as 5-nitrofurfural diethyl ester) in the presence of a suitable solvent and catalyst.
(2) The reaction is usually carried out at a certain temperature and requires control of reaction time and temperature to ensure high yield and purity.
C3H6N2O2+C9H11NO8 → C8H7N3O5+byproduct
Note: The by-products here may include water, alcohol, etc., depending on the reaction conditions and solvent selection.
Steps:
(1) After the reaction is complete, cool the reaction solution to room temperature and filter it to remove insoluble substances.
(2) Wash and dry the filtrate to remove solvents and residues.
(3) If necessary, methods such as recrystallization can be used to further improve the purity of the product.
Ethanolamine (HOCH2CH2NH2) and urea (H2NCONH2) undergo condensation reaction in the presence of acidic catalyst (such as hydrochloric acid) at an appropriate temperature. This reaction will remove one molecule of water and form β - hydroxyethyl urea (also known as N-aminoformylethanolamine).
HOCH2CH2NH2+H2NCONH2 → HClH2NCOCH2CH2NHCONH2+H2O
β - Hydroxyethylurea reacts with nitrous acid (usually generated by reacting sodium nitrite with acid) under acidic conditions for nitrosation. This step will introduce nitro (- NO2) groups, but the specific product depends on the reaction conditions and subsequent processing. In this assumption, we assume that a nitration intermediate is generated, which will subsequently undergo cyclization.
H2NCOCH2CH2NHCONH2+HNO2 → Intermediate (nitration)
Due to the complexity of the nitrosation process and the potential involvement of multiple steps and intermediates, no specific product structure has been provided.
The intermediate that has undergone nitrosation undergoes cyclization reaction under appropriate conditions (such as heating, presence of catalyst, etc.) to form a structure containing an oxazolidinone ring. This step is crucial for the formation of 3-nitro-2-oxazolidinone (or similar nitro compounds, which subsequently need to be reduced to amino groups). Then, 3-nitro-2-oxazolidinone needs to be reduced to 3-amino-2-oxazolidinone, which can be achieved through iron powder or other reducing agents under acidic or alkaline conditions.
3-amino-2-oxazolidinone (assuming to have undergone reduction treatment, although it may not be directly reduced in standard synthesis) reacts with 5-nitrofurfural diethyl ester in the presence of appropriate solvents and catalysts (such as base) to produce the diethyl derivative of furazolidone. This step is the core step in the synthesis of furazolidone.
3-amino-2-oxazolidinone+5-nitrofurfural diethyl ester → furazolidone diethyl ester
Use a conventional acid or base catalyzed hydrolysis reaction to obtain furazolidone from diethyl furazolidone.
Furazolidone diethyl ester+acid/base → Furazolidone+ethyl ethanoate
(Note: In actual reactions, other by-products such as ethanol may be generated, which are omitted here for simplicity.)
After hydrolysis reaction, the obtained furazolidone mixture needs to undergo a series of purification steps to remove impurities such as unreacted raw materials, by-products, and solvents. This usually includes steps such as filtration, washing, drying, crystallization, or distillation. The specific purification method depends on the nature of the impurities and the purity requirements of the target Furazolidone powder.
Hot Tags: furazolidone powder cas 67-45-8, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale, CAS 1869059 10 8, 7 bromodibenzo c h acridine, CAS 2377545 66 7, Tricyclo 3 3 1 13 7 decane 1 4 chloro 1 1 4 1 terphenyl 4 yl , 4 4 5 5 tetramethyl 2 6 phenyl 1 1 2 1 terphenyl 4 yl 1 3 2 dioxaborolane, Synthetic Chemical